Safety and efficacy of MEDI4736, an anti-PD-L1 antibody, in patients from a squamous cell carcinoma of the head and neck (SCCHN) expansion cohort Meeting Abstract
| Authors: | Segal, N. H.; Ou, S. H. I.; Balmanoukian, A. S.; Fury, M. G.; Massarelli, E.; Brahmer, J. R.; Weiss, J.; Schöffski, P.; Antonia, S. J.; Massard, C.; Zandberg, D. P.; Khleif, S.; Li, X.; Rebelatto, M.; Steele, K.; Robbins, P. B.; Blake-Haskins, J. A.; Butler, M. O. |
| Abstract Title: | Safety and efficacy of MEDI4736, an anti-PD-L1 antibody, in patients from a squamous cell carcinoma of the head and neck (SCCHN) expansion cohort |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036900645 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2015.33.15_suppl.3011 |
| Notes: | Meeting Abstract: 3011 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
